Husband Support in Implementation of Dynamic Cancer Detection Method of Visual Acetic Acid (IVA) Inspection in Kediri

Fauzia Laili, Eko Winarti, Dewi Kartika Sari, Halimatus Saidah

Abstract


The World Health Organization (WHO) states, cervical cancer currently take the highest rank  among various types of cancer that cause death in women in the world. Most women diagnosed with cervical cancer do not do screening tests or do not follow up after finding abnormal results. The purpose of this study was to determine the relationship between husband's support and the implementation of early detection of cervical cancer using the Visual Acetate (IVA) Inspection method in Kediri, Indonesia. This study used a cross sectional design with a sample of 205 respondents. Sampling is done by simple random sampling method. The research instrument uses a questionnaire that has been tested for validity and reliability. Data analysis using the Spearman rho test. Based on statistical tests, husband's support has a significant relationship with the implementation of cervical cancer early detection method IVA (p value = 0,000) in Kediri, with moderate relationship strength (correlation coefficient = 0.62) and the direction of positive relationships means the better support from husband then women will be more obedient in the early detection of cervical cancer IVA method. Based on the results of these studies, it is recommended that health workers should involve their husbands or families to participate in providing support to their wives to carry out routine screening tests for cervical cancer in the IVA method.

Full Text:

PDF

References


Kementerian Kesehatan RI, Stop Kanker. Jakarta Selatan: Kementerian Kesehatan RI, 2015.

Y. Jia et al., “Knowledge about Cervical Cancer and Barriers of Screening Program among Women in Wufeng County , a High-Incidence Region of Cervical Cancer in China,” vol. 8, no. 7, pp. 2–8, 2013.

D. TT, “The health-care practices of Vietnamese-Canadian women: cultural influences on breast and cervical cancer screening,” Can J Nurs Res, pp. 82–101, 2006.

J. L., B. S., W. R., H. F.C., and P. A.A.W., “Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: A cross-sectional study,” Vaccine, vol. 29, no. 44. pp. 7785–7793, 2011.

M. Wahidin, “Deteksi dini kanker leher rahim dan kanker payudara di Indonesia 2007-2014,” Bul. jendela dan data Inf. Kesehat., vol. 1, no. 1, pp. 12–15, 2015.

S. S. and S. Badaya, “Factors Influencing uptake of Cervical Cancer Screening among Women in India: A Hospital based Pilot Study,” vol. 12, no. Supplement 2, pp. 77–80, 2015.

B. Irawati, “Regression ( GPR ) dan Regresi Binomial Negatif,” vol. 2, no. 2, pp. 13–24, 2012.

A. Khosidah and Y. Trisnawati, “Faktor yang mempengaruhi ibu rumah tangga dalam melakukan TES IVA sebagai upaya deteksi dini kanker serviks,” J. Ilm. Kebidanan, vol. 6, no. 2, pp. 94– 105, 2015.

S. H. Lee, J. S. Vigliotti, V. S. Vigliotti, and W. Jones, “From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice,” pp. 2072–2099, 2014.

E. Bailon Muñoz, “Cervical cancer screening interval can be extended to six years after a negative HPV test: European multicentric study,” FMC Form. Medica Contin. en Aten. Primaria, 2009.

World Health Organisation, “Comprehensive Cervical Cancer Control,” WHO Libr. Cat. Data, p. 364, 2014.

L. Jaspers, Peraturan Menteri Kesehatan Republik Indonesia. Jakarta: Kementerian Kesehatan RI, 2015.

E. J. Domingo et al., “Epidemiology and Prevention of Cervical Cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam,” Vaccine, vol. 26, no. SUPPL. 12, 2008.

I. K. Suwiyoga, “Beberapa masalah papsmear sebagai alat diagnosis dini kanker serviks di Indonesia,” J. Jender Srikandi, vol. 3, no. 1, pp. 1–7, 2003.

G. B. S. and M. N. Bo T Hansen*, Silje S Hukkelberg, Tor Haldorsen, Tormod Eriksen, Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women, vol. 38. 2011, pp. 82–101.

B. T. Hansen, S. S. Hukkelberg, T. Haldorsen, T. Eriksen, G. B. Skare, and M. Nygård, “Factors associated with non-attendance , opportunistic attendance and reminded attendance to cervical screening in an organized screening program : a cross-sectional study of 12 , 058 Norwegian women,” 2011.

K. Ackerson and S. D. Preston, “A decision theory perspective on why women do or do not decide to have cancer screening: Systematic review,” Journal of Advanced Nursing. 2009.

S. DE Austin LT1, Ahmad F, McNally MJ, “Breast and cervical cancer screening in Hispanic women: a literature review using the health belief model,” Women Helath Issues, vol. 3, pp. 122– 8, 2002.

F. Fylan, “Screening for cervical cancer : a review of women ’ s attitudes , knowledge , and behaviour,” no. August, pp. 1509–1514, 1991.

T. N. Adi, “WANITA DAN DETEKSI DINI KANKER SERVIKS (Studi Korelasi antara Sikap dan Norma Subjektif dengan Intensi Wanita Dewasa dalam Pemeriksaan Deteksi Dini Kanker Serviks),” 1991.

P. M. P. R. R. M. B. C. Ed, “Cervical cancer,” BMC Public Health, vol. 11, no. 1, p. 264, 2011.

K. Bosompra, “Psychosocial factors associated with the public’s willingness to pay for genetic testing for cancer risk: a structural equations model,” Health Educ. Res., vol. 16, no. 2, pp. 157– 172, Apr. 2001.

A. T. Brenner, L. K. Ko, N. Janz, S. Gupta, and J. Inadomi, “Race/Ethnicity and Primary Language: Health Beliefs about Colorectal Cancer Screening in a Diverse, Low-Income Population,” J. Health Care Poor Underserved, 2015.

L. Botterill and N. Mazur, “Risk & risk perception: A literature review,” 2004.

J. W. and A. Weyman, “Review of the Public Perception of Risk, and Stakeholder Engageme,”2005.


Refbacks

  • There are currently no refbacks.